Novolog Pharm-Up 1966 Ltd (NVLG) — Capital Reinvestment Ratio
Novolog Pharm-Up 1966 Ltd (NVLG) has a Capital Reinvestment Ratio of 1.41x as of September 2025, meaning it reinvests 1% of its operating cash flow (ILA15.42 Million) in capital expenditures (ILA21.78 Million). Check Novolog Pharm-Up 1966 Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Novolog Pharm-Up 1966 Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks Novolog Pharm-Up 1966 Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Novolog Pharm-Up 1966 Ltd.
Annual Capital Reinvestment Ratio for Novolog Pharm-Up 1966 Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for Novolog Pharm-Up 1966 Ltd from 2014 to 2024. See Novolog Pharm-Up 1966 Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.37x | ILA158.52 Million | ILA58.74 Million | ▲ +4.4% |
| 2023 | 0.35x | ILA200.01 Million | ILA70.95 Million | ▼ -32.3% |
| 2022 | 0.52x | ILA132.65 Million | ILA69.49 Million | ▲ +42.6% |
| 2021 | 0.37x | ILA83.39 Million | ILA30.64 Million | ▼ -16.1% |
| 2020 | 0.44x | ILA58.48 Million | ILA25.61 Million | ▲ +77.6% |
| 2019 | 0.25x | ILA101.45 Million | ILA25.01 Million | ▼ -79.8% |
| 2018 | 1.22x | ILA23.96 Million | ILA29.27 Million | ▲ +202.4% |
| 2017 | 0.40x | ILA86.37 Million | ILA34.89 Million | ▼ -38.5% |
| 2016 | 0.66x | ILA20.28 Million | ILA13.32 Million | ▲ +700.7% |
| 2015 | 0.08x | ILA140.29 Million | ILA11.50 Million | ▲ +381.8% |
| 2014 | 0.02x | ILA160.59 Million | ILA2.73 Million | — |